Premier Fund Managers LTD Amgen Inc Transaction History

Premier Fund Managers LTD

$2.49 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $8.92 Million - $11.3 Million	-38,953 Reduced 92.06%	3,360 $884,000
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $9.69 Million - $12.3 Million	42,313 New	42,313 $545,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $115,355 - $128,370	500 Added 21.19%	2,860 $580,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $59,664 - $68,280	300 Added 14.56%	2,360 $535,000
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $93,432 - $103,656	-400 Reduced 16.26%	2,060 $499,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $4.45 Million - $5.9 Million	-24,427 Reduced 90.85%	2,460 $513,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $894,395 - $1.15 Million	-4,727 Reduced 14.95%	26,887 $6.46 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $271,785 - $325,655	1,561 Added 5.19%	31,614 $6.16 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $22,337 - $26,184	134 Added 0.45%	30,053 $5.53 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $864,196 - $974,138	4,778 Added 19.0%	29,919 $5.17 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $465,267 - $543,116	2,608 Added 11.57%	25,141 $4.89 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $409,120 - $461,229	2,208 Added 10.86%	22,533 $0
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $316,823 - $355,861	1,908 Added 10.36%	20,325 $0
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $5.43 Million - $6.07 Million	-32,179 Reduced 63.6%	18,417 $0
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $5.49 Million - $6.14 Million	32,535 Added 180.14%	50,596 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $273,184 - $311,903	1,633 Added 9.94%	18,061 $0
Q2 2017 Aug 14, 2017	BUY	N/A	16,428	16,428 $2.84 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.

Account